Related Experiment Videos

Analysis of risk factors for multidrug-resistant bacterial infections in intensive care units and application of a

Yi Fu1, Xing-Ran Zhao, Jian-Jun Luo

  • 1Leshan People's Hospital, Leshan, Sichuan, China.

Medicine
|July 18, 2026
PubMed

Insights

Multidrug-resistant bacterial infections pose a significant threat in intensive care units. A new nomogram model effectively predicts patient risk, aiding early intervention strategies for these challenging infections.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Multidrug-resistant (MDR) bacterial infections are a critical concern in intensive care units (ICUs), contributing to increased mortality and prolonged hospital stays.
  • Existing clinical factors for MDR infections lack practical, individualized predictive tools for early risk stratification in ICU patients.

Purpose of the Study:

  • To develop and validate a nomogram prediction model for early risk stratification of multidrug-resistant bacterial infections in intensive care unit patients.
  • To identify independent risk factors associated with the development of MDR bacterial infections in the ICU.

Main Methods:

  • Retrospective single-center study of 876 adult ICU patients (January 2020-December 2025).
  • Patients divided into training (70%) and validation (30%) cohorts.
  • Multivariable logistic regression and nomogram construction, with performance evaluated using ROC curves, AUC, calibration, and internal validation.

Main Results:

  • 18.38% of patients developed MDR bacterial infections.
  • Independent risk factors identified: age > 75 years, endotracheal intubation, ICU stay > 1 week, coma, and central venous catheterization.
  • The nomogram showed good discriminative ability (AUC 0.827 training, 0.812 validation) and internal validation (AUC 0.820).

Conclusions:

  • Advanced age, invasive procedures, prolonged ICU stay, and impaired consciousness are associated with increased risk of MDR infections in ICU patients.
  • The developed nomogram serves as a practical tool for individualized risk prediction, assisting clinicians in early identification and targeted prevention.
  • Findings suggest associations, but causality requires further investigation due to the study's retrospective nature.

Related Concept Videos

Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).